Related Experiment Video
Updated: Aug 1, 2026
14:39
Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Phenotypic diversity in hypertrophic cardiomyopathy.
Michael Arad1, J G Seidman, Christine E Seidman
1Department of Genetics, Harvard Medical School, Boston, MA, USA.
Human Molecular Genetics
|September 28, 2002
Summary
Human genetic studies now focus on hypertrophic cardiomyopathy (HCM) mutation distribution to understand genotype-phenotype links. This research aids in developing targeted treatments and evaluating therapies using animal models.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Epidemiology
Background:
- Hypertrophic cardiomyopathy (HCM) is a common inherited heart muscle disease.
- Recent research shifts focus from gene discovery to mutation distribution in patient populations.
- Understanding genetic heterogeneity is crucial for personalized medicine.
Purpose of the Study:
- To review the clinical spectrum of HCM in relation to its genetic diversity.
- To discuss advancements in understanding molecular pathways of cardiac hypertrophy.
- To explore the role of genetic factors in modifying HCM phenotypes.
Main Methods:
- Literature review of recent genetic and clinical studies on HCM.
- Analysis of genotype-phenotype correlations in hypertrophic cardiomyopathy.
- Discussion of findings from genetically engineered animal models of HCM.
Main Results:
- Shift in focus towards mutation distribution and genotype-phenotype relationships in HCM.
- Identification of key molecular pathways involved in cardiac hypertrophy.
- Validation of animal models for studying HCM pathogenesis and therapeutic strategies.
Conclusions:
- Understanding genetic variations in HCM is key to deciphering disease mechanisms.
- Genotype-phenotype correlations will guide personalized treatment strategies for HCM.
- Animal models are essential for preclinical evaluation of novel HCM therapies.
Related Concept Videos
01:27Specialized Characteristics of Cardiac Muscles
The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...